The positions in the table below reflect the Centre for Clinical Research in Neuropsychiatry (CCRN)'s position overall, domestically, within their sector, and in various subject areas based on their ...

Cross Country Healthcare Inc (NASDAQ:CCRN) is set to release its Q3 2024 earnings on Nov 6, 2024. The consensus estimate for Q3 2024 revenue is $310.22 million, and the earnings are expected to come ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside ...

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.19 per share a year ago.

CCRN is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of CCRN shares has decreased $0.07 since the market last closed. This is a 0.71 ...